Cellular, animal and computational models of the disease are providing fresh insights into biology and treatment.

The latest research published in Genes & Diseases unveils groundbreaking insights into the role of the aging process and the associated factor EMP1 in the progression of resectable pancreatic cancer ...

Immunitybio Inc ($IBRX) announced an update on their ongoing clinical study. Study Overview: ImmunityBio Inc. has completed a Phase 1b/2 clinical ...

Groundbreaking research has uncovered genetic patterns associated with pancreatic cancer, a discovery that could ...

Peptidyl-arginine deiminase 2 (PAD2) enzyme converts arginine amino acid residues in histone proteins into citrulline groups and promotes tumor cell proliferation in pancreatic ductal adenocarcinoma, ...

Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most challenging malignancies to treat.  Further, PDAC incidence ...

Combined preoperative segmental hepatic arteries embolization with hepatic artery resection in radical pancreatic resections for locally advanced pancreatic cancer. Univariate and multivariate cox ...

A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...